Author(s):
Seba Mawafak, Shn Bashar Zainulabdeen, Kais A Najem, Amal Mayyas, Amjad I Oraibi, Zahraa Salam Al-Tameemi, Hany A. Al-hussaniy, Fatima Akeel naji, Ali Hikmat Alburghaif, Mohammed K. Al iraqi, Meena akeel Naji
Email(s):
hanyakeel2018@gmail.com
DOI:
10.52711/0974-360X.2024.00712
Address:
Seba Mawafak1, Shn Bashar Zainulabdeen2, Kais A Najem3, Amal Mayyas4, Amjad I Oraibi5, Zahraa Salam Al-Tameemi6, Hany A. Al-hussaniy6*, Fatima Akeel naji6, Ali Hikmat Alburghaif7, Mohammed K. Al iraqi6, Meena akeel Naji6
1Department Family Medicine, College of Medicine, Baghdad, Iraq.
2Pharmacy Department, Al-Karkh Baghdad Health Department, Ministry of Health Iraq.
3Department of clinical Pharmacy, College of Pharmacy , Univeristy of Baghdad, Iraq.
4Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, 11821, Jordan.
5Al-Manara College for Medical Sciences, Department of Pharmacy, Amarah, Iraq.
6 Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, 10001, Iraq.
7Department of pharmaceutical chemistry , Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 17,
Issue - 9,
Year - 2024
Cite this article:
Seba Mawafak, Shn Bashar Zainulabdeen, Kais A Najem, Amal Mayyas, Amjad I Oraibi, Zahraa Salam Al-Tameemi, Hany A. Al-hussaniy, Fatima Akeel naji, Ali Hikmat Alburghaif, Mohammed K. Al iraqi, Meena akeel Naji. Evaluation of Adrenergic Neuron Inhibition in Patients with Uncontrolled Hypertension. Research Journal of Pharmacy and Technology. 2024; 17(9):4613-0. doi: 10.52711/0974-360X.2024.00712